The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2025
Filed:
Jan. 09, 2024
Applicant:
Heron Therapeutics, Inc., San Diego, CA (US);
Inventors:
Thomas B. Ottoboni, Belmont, CA (US);
Han Han, Mountain View, CA (US);
Assignee:
Heron Therapeutics, Inc., San Diego, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/10 (2005.12); A61K 9/00 (2005.12); A61K 9/107 (2005.12); A61K 31/00 (2005.12); A61K 31/5377 (2005.12); A61K 31/573 (2005.12); A61K 47/10 (2016.12); A61K 47/12 (2005.12); A61K 47/18 (2016.12); A61K 47/24 (2005.12); A61K 47/26 (2005.12); A61K 47/44 (2016.12);
U.S. Cl.
CPC ...
A61K 31/5377 (2012.12); A61K 9/0019 (2012.12); A61K 9/0024 (2012.12); A61K 9/107 (2012.12); A61K 31/573 (2012.12); A61K 47/10 (2012.12); A61K 47/12 (2012.12); A61K 47/18 (2012.12); A61K 47/24 (2012.12); A61K 47/26 (2012.12); A61K 47/44 (2012.12);
Abstract
Disclosed herein are novel pharmaceutical formulations of aprepitant suitable for parenteral administration including intravenous administration. Also included are formulations including both aprepitant and dexamethasone sodium phosphate. The pharmaceutical formulations are stable oil-in-water emulsions for non-oral treatment of emesis and are particularly useful for treatment of subjects undergoing highly emetogenic cancer chemotherapy.